How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers

4Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Although data sharing platforms host diverse data types the features of these platforms are well-suited to facilitating biomarker research. Given the current state of biomarker discovery, an innovative paradigm to accelerate biomarker discovery is to utilize platforms such as Vivli to leverage researchers' abilities to integrate certain classes of biomarkers.

Cite

CITATION STYLE

APA

Li, R., & Sim, I. (2019). How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers. Journal of Law, Medicine and Ethics, 47(3), 369–373. https://doi.org/10.1177/1073110519876165

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free